Middle East & Africa Menopause Market Size & Outlook

The menopause market in Middle East & Africa is expected to reach a projected revenue of US$ 307.8 million by 2030. A compound annual growth rate of 6.4% is expected of Middle East & Africa menopause market from 2025 to 2030.
Revenue, 2024 (US$M)
$212.5
Forecast, 2030 (US$M)
$307.8
CAGR, 2025 - 2030
6.4%
Report Coverage
Middle East & Africa

MEA menopause market highlights

  • The MEA menopause market generated a revenue of USD 188.9 million in 2022.
  • The market is expected to grow at a CAGR of 6.3% from 2023 to 2030.
  • In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
  • Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.
  • Country-wise, South Africa is expected to register the highest CAGR from 2023 to 2030.


MEA data book summary

Market revenue in 2022USD 188.9 million
Market revenue in 2030USD 307.8 million
Growth rate6.3% (CAGR from 2022 to 2030)
Largest segmentDietary supplements
Fastest growing segmentDietary Supplements
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOTC pharma products, Dietary Supplements
Key market players worldwideBayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis


Other key industry trends

  • In terms of revenue, MEA region accounted for 1.2% of the global menopause market in 2022.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
  • Latin America is the fastest growing regional market and is projected to reach USD 1,618.6 million by 2030.

Dietary supplements was the largest segment with a revenue share of 84.01% in 2024. Horizon Databook has segmented the Middle East & Africa menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.


Government initiatives to improve women’s health and expenditure on health are positively impacting the market. However, cultural taboo regarding menopause, and lack of a supportive attitude toward menopause treatment, and lack of general education on menopause can hinder the adoption of dietary supplements in the region.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Menopause Market Scope

Menopause market segmentation & scope
Hormonal
Non-Hormonal
Dietary Supplements
Countries
UK
Sweden
Norway
Denmark
Australia
Thailand
Argentina
Saudi Arabia
UAE
Kuwait

Menopause Market Companies

Name Profile # Employees HQ Website

MEA menopause market size, by country, 2018-2030 (US$M)

Middle East & Africa Menopause Market Outlook Share, 2024 & 2030 (US$M)

MEA menopause market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more